WO2002064776A3 - Proteines de transduction de signal 15b3, 15b3-1 et 15b3-2 et sequences d'adn associees - Google Patents

Proteines de transduction de signal 15b3, 15b3-1 et 15b3-2 et sequences d'adn associees Download PDF

Info

Publication number
WO2002064776A3
WO2002064776A3 PCT/EP2002/001562 EP0201562W WO02064776A3 WO 2002064776 A3 WO2002064776 A3 WO 2002064776A3 EP 0201562 W EP0201562 W EP 0201562W WO 02064776 A3 WO02064776 A3 WO 02064776A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna sequences
signal transduction
transduction proteins
gene products
related dna
Prior art date
Application number
PCT/EP2002/001562
Other languages
German (de)
English (en)
Other versions
WO2002064776A2 (fr
Inventor
Armin Schneider
Achim Fischer
Bettina Klausner
Moritz Rossner
Birgitta Kammandel
Rebecca Widenmeyer
Bernhard Goetz
Gisela Eisenhardt
Stephanie Jomana Naim
Dieter Newrzella
Original Assignee
Axaron Bioscience Ag
Armin Schneider
Achim Fischer
Bettina Klausner
Moritz Rossner
Birgitta Kammandel
Rebecca Widenmeyer
Bernhard Goetz
Gisela Eisenhardt
Stephanie Jomana Naim
Dieter Newrzella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axaron Bioscience Ag, Armin Schneider, Achim Fischer, Bettina Klausner, Moritz Rossner, Birgitta Kammandel, Rebecca Widenmeyer, Bernhard Goetz, Gisela Eisenhardt, Stephanie Jomana Naim, Dieter Newrzella filed Critical Axaron Bioscience Ag
Priority to AU2002250943A priority Critical patent/AU2002250943A1/en
Publication of WO2002064776A2 publication Critical patent/WO2002064776A2/fr
Publication of WO2002064776A3 publication Critical patent/WO2002064776A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des séquences d'ADN, des vecteurs d'expression contenant des séquences d'ADN objets de l'invention, des cellules hôtes, des produits géniques des séquences d'ADN précitées codant pour des protéines de transduction de signal, ainsi que d'autres dérivés des objets de l'invention précités. L'invention concerne en outre l'utilisation de séquences d'ADN objets de l'invention ou de protéines de transduction de signal exprimées par ces séquences d'ADN comme produits pharmaceutiques, ainsi que des utilisations non thérapeutiques de séquences d'ADN et produits géniques objets de l'invention.
PCT/EP2002/001562 2001-02-14 2002-02-14 Proteines de transduction de signal 15b3, 15b3-1 et 15b3-2 et sequences d'adn associees WO2002064776A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002250943A AU2002250943A1 (en) 2001-02-14 2002-02-14 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106835.2 2001-02-14
DE10106835A DE10106835A1 (de) 2001-02-14 2001-02-14 Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen

Publications (2)

Publication Number Publication Date
WO2002064776A2 WO2002064776A2 (fr) 2002-08-22
WO2002064776A3 true WO2002064776A3 (fr) 2003-08-21

Family

ID=7674010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001562 WO2002064776A2 (fr) 2001-02-14 2002-02-14 Proteines de transduction de signal 15b3, 15b3-1 et 15b3-2 et sequences d'adn associees

Country Status (3)

Country Link
AU (1) AU2002250943A1 (fr)
DE (1) DE10106835A1 (fr)
WO (1) WO2002064776A2 (fr)

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037210A1 (fr) * 1997-02-21 1998-08-27 KANTON ZÜRICH vertreten durch DIE ERZIEHUNGSDIREKTION Detection immunologique de prions
WO1999014328A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO2001004311A1 (fr) * 1999-07-07 2001-01-18 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001022920A2 (fr) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Polynucleotides et polypeptides associes au colon et au cancer du colon
WO2001055326A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
EP1130094A2 (fr) * 1999-07-08 2001-09-05 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
WO2001090304A2 (fr) * 2000-05-19 2001-11-29 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001093983A1 (fr) * 2000-06-02 2001-12-13 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides
WO2002000690A2 (fr) * 2000-06-23 2002-01-03 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
WO2002008288A2 (fr) * 2000-07-20 2002-01-31 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037210A1 (fr) * 1997-02-21 1998-08-27 KANTON ZÜRICH vertreten durch DIE ERZIEHUNGSDIREKTION Detection immunologique de prions
WO1999014328A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO2001004311A1 (fr) * 1999-07-07 2001-01-18 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
EP1130094A2 (fr) * 1999-07-08 2001-09-05 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001022920A2 (fr) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Polynucleotides et polypeptides associes au colon et au cancer du colon
WO2001055326A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
WO2001090304A2 (fr) * 2000-05-19 2001-11-29 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001093983A1 (fr) * 2000-06-02 2001-12-13 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides
WO2002000690A2 (fr) * 2000-06-23 2002-01-03 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
WO2002008288A2 (fr) * 2000-07-20 2002-01-31 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
DATABASE EPOP [online] 1 March 2002 (2002-03-01), BAKER K.P. ET AL.: "Secreted and transmembrane polypeptides and nucleic acids encoding the same", XP002214593, Database accession no. AX376345 *
DATABASE EPOP [online] 13 February 2002 (2002-02-13), BAKER K.P. ET AL.: "Secreted and transmembrane polypeptides and nucleic acids encoding the same", XP002214597, Database accession no. AX358871 *
DATABASE EPOP [online] 15 February 2002 (2002-02-15), BAKER K.P. ET AL.: "Secreted and transmembrane polypeptides and nucleic acids encoding the same", XP002214596, Database accession no. AX362364 *
DATABASE GSP [online] 16 May 2002 (2002-05-16), BAKER K.P.: "Human PRO247 protein sequence SEQ ID NO:40", XP002214595, Database accession no. ABB84836 *
DATABASE GSP [online] 24 April 2001 (2001-04-24), ASHKENAZI A.J. ET AL.: "Human PRO247 protein", XP002214589, Database accession no. AAB80254 *
DATABASE GSP [online] 24 May 2002 (2002-05-24), BIRSE C.E. ET AL.: "Human polypeptide SEQ ID NO:2312", XP002214598, Database accession no. ABB89936 *
DATABASE GSP [online] 26 June 2001 (2001-06-26), OTA T. ET AL.: "Human protein sequence SEQ ID NO:14536", XP002214592, Database accession no. AAB94199 *
DATABASE GSP [online] 3 September 2001 (2001-09-03), RUBEN S.M. ET AL.: "Human colon cancer antigen protein SEQ ID NO:6177", XP002214590, Database accession no. AAG75413 *
DATABASE GSP [online] 4 December 2001 (2001-12-04), ROSEN C.A. ET AL.: "Human secreted protein SEQ ID NO:418", XP002214594, Database accession no. AAU20426 *
DATABASE GSP [online] 6 November 2001 (2001-11-06), OTA T. ET AL.: "Human polypeptide SEQ ID NO:3764", XP002214591, Database accession no. AAM93765 *
NAGASE T ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES. XVI THE COMPLETE SEQUENCES OF 150 NEW CDNA CLONES FROM BRAIN WHICH CODE FOR LARGE PROTEINS IN VITRO", DNA RESEARCH, vol. 7, 2000, pages 65 - 73, XP000949814, ISSN: 1340-2838 *

Also Published As

Publication number Publication date
AU2002250943A1 (en) 2002-08-28
WO2002064776A2 (fr) 2002-08-22
DE10106835A1 (de) 2002-09-05

Similar Documents

Publication Publication Date Title
WO2002086144A3 (fr) Compositions et procedes destines au clonage recombinant de molecules d'acides nucleiques
WO2005121331A8 (fr) Polypeptides galnact2 tronques et acides nucleiques
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
WO2003080807A3 (fr) Compositions et methodes destinees a supprimer l'expression de genes eucaryotes
WO2005001064A3 (fr) Polypeptides a activite alpha-amylase et polynucleotides codant pour ceux-ci
WO2004001012A3 (fr) Defensines vegetales
WO2000066739A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
WO2002074807A3 (fr) Immunoadhesines d'erythropoietine de chimpanze (chepo)
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO2005024006A8 (fr) Polypeptides du facteur vii de coagulation
WO2001046225A3 (fr) Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
AU6724794A (en) GRB3-3 gene, its variants and their uses
EP0953641A3 (fr) Molécules nucléotidiques encodant des protéines de Neospora
WO1999014337A3 (fr) Nouveaux genes de plantes
WO2001074863A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants, et utilisations desdits fragments
WO2002064776A3 (fr) Proteines de transduction de signal 15b3, 15b3-1 et 15b3-2 et sequences d'adn associees
WO2001075114A3 (fr) Antigenes de $i(chlamydia) et fragments d'adn correspondants, et leur utilisation
WO2001072974A3 (fr) Sequence genique
WO2005055930A3 (fr) Facteur viii recombine presentant une activite specifique amelioree
WO2002010336A3 (fr) Genes de biosynthese de la mutacine i et proteines associees
EP2172214A3 (fr) Antigènes de Chlamydia et fragments d'ADN correspondants, et leurs utilisations
WO2004087912A8 (fr) Proteines inhibitrices d'une protease et leurs utilisations
WO2002006508A3 (fr) Cgtase et sequence d'adn codant celle-ci
WO2004011667A3 (fr) Molecules de geranyle diphosphate synthase, et molecules d'acide nucleique codant ces molecules
WO2000006742A3 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP